Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Completed · Phase 2 · Has a placebo group
Conditions studied: Acquired Immunodeficiency Syndrome, HIV Infections
In brief
The primary objective of this study is to evaluate the efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (Genvoya®; E/C/F/TAF) fixed-dose combination (FDC) versus elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (Stribild®; E/C/F/TDF) FDC in HIV-1 infected, antiretroviral treatment-naive adults.
Key facts
- Study ID
- NCT01497899
- Run by
- Gilead Sciences
- People needed
- 279
- Starts
- 2011-12-28
- Expected to finish
- 2016-08-22
- Last updated by the study team
- 2018-11-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham (UAB) — Birmingham, Alabama, United States
- Spectrum Medical Group — Phoenix, Arizona, United States
- AHF Research Center — Beverly Hills, California, United States
- Kaiser Permanente — Los Angeles, California, United States
- Peter J. Ruane, MD, Inc. — Los Angeles, California, United States
- Anthony Mills MD, Inc — Los Angeles, California, United States
- East Bay AIDS Center — Oakland, California, United States
- St. Joseph Heritage Healthcare — Orange, California, United States
- Stanford University — Palo Alto, California, United States
- Kaiser Permanente Medical Group — Sacramento, California, United States
- La Playa Medical Group and Clinical Research — San Diego, California, United States
- Metropolis Medical — San Francisco, California, United States
- Kaiser Permanente Medical Group-Clinical Trials Unit — San Francisco, California, United States
- Apex Research, LLC — Denver, Colorado, United States
- Dupont Circle Physician's Group — Washington D.C., District of Columbia, United States
- Whitman-Walker Health — Washington D.C., District of Columbia, United States
- Capital Medical Associates, PC — Washington D.C., District of Columbia, United States
- Gary J. Richmond,M.D.,P.A. — Fort Lauderdale, Florida, United States
- Wohlfeiler, Piperato and Associates, LLC — Miami Beach, Florida, United States
- Orlando Immunology Center — Orlando, Florida, United States
- IDOCF/ValuhealthMD, LLC — Orlando, Florida, United States
- St. Joseph's Comprehensive Research Institute — Tampa, Florida, United States
- Infectious Disease Specialists of Atlanta — Decatur, Georgia, United States
- Mercer University Mercer Medicine — Macon, Georgia, United States
- Howard Brown Health Center — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.